Frontlight ResearchEarly access
Trial site
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
- 3running trials
- 5closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- High blood pressure2 trials
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Psoriasis1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2 trials
- Huabo Biopharm Co., Ltd.1 trial
- Shanghai Pharmaceuticals Holding Co., Ltd1 trial
- Westlake University1 trial
Running trials
Recruiting
Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
Closed trials
Completed
Withdrawn
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026